Brief: Psychogenics Announces Extension Of Ongoing Drug Discovery Collaboration With Karuna Therapeutics
11/10/2022 14:06
Oct 11 (Reuters) - Karuna Therapeutics Inc KRTX.O :
* PSYCHOGENICS ANNOUNCES EXTENSION OF ONGOING DRUG DISCOVERY
COLLABORATION WITH KARUNA THERAPEUTICS
Source text for Eikon: ID:nBwc5HW3Ra
Further company coverage: KRTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Karuna Therapeutics
See all newsMoody's says pharma outlook turns 'positive' on GLP-1 drug push
Brief: Karuna Therapeutics Says Complaint Was Filed By Karuna Stockholder Seeking To Enjoin Proposed Merger With Bristol-Myers Squibb
Karuna Therapeutics Inc reports results for the quarter ended in December - Earnings Summary
Karuna Therapeutics Inc expected to post a loss of $2.65 a share - Earnings Preview
Bristol Myers posts better-than-expected 4th-quarter results (updated)